Concomitant genetic alterations having greater impact on the clinical benefit of EGFR‐TKIs in EGFR‐mutant advanced NSCLC than BIM deletion polymorphism

BACKGROUND: In previous studies, the predictive role of BIM deletion polymorphism with respect to responses to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR‐TKIs) has been controversial. The potential reasons for these inconsistent findings were unknown. METHODS: Data from CTONG0...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Si‐Yang, Zhou, Jia‐Ying, Li, Wen‐Feng, Sun, Hao, Zhang, Yi‐Chen, Yan, Hong‐Hong, Chen, Zhi‐Hong, Chen, Chun‐Xiang, Ye, Jun‐Yi, Yang, Jin‐Ji, Zhou, Qing, Zhang, Xu‐Chao, Wu, Yi‐Long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7240862/
https://www.ncbi.nlm.nih.gov/pubmed/32508032
http://dx.doi.org/10.1002/ctm2.12

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7240862/
https://www.ncbi.nlm.nih.gov/pubmed/32508032
http://dx.doi.org/10.1002/ctm2.12

Ejemplares similares